[{"Assets_0_Q1_USD":38006800000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":311300000.0,"NetIncomeLossConverted_1_Q1_USD":4241600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":984000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":979900000.0,"StockholdersEquity_0_Q1_USD":2480300000.0,"StockholdersEquityConverted_0_Q1_USD":2565000000.0,"EarningsPerShareBasic_1_Q1_USD":4.33,"EarningsPerShareDiluted_1_Q1_USD":4.31,"RevenuesConverted_1_Q1_USD":5092200000.0,"Ticker":"LLY","CIK":"59478","name":"LILLY ELI & CO","OfficialName":"Eli Lilly and Company Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"282857000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190502"}]